摘要
目的探讨采用丙卡特罗联合西替利嗪治疗小儿咳嗽变异性哮喘的临床效果。方法随机选取2014年8月至2015年7月本院收治的咳嗽变异性哮喘患儿90例,采用随机数字表法将其分为对照组和观察组,其中对照组患儿仅采用丙卡特罗进行治疗,观察组则联合西替利嗪进行治疗,对两组患儿的临床治疗效果进行回顾性分析。结果观察组患儿经治疗其中91.11%症状得到有效缓解,对照组则为75.56%,观察组患儿的整体治疗效果明显优于对照组,差异具有显著性(P<0.05)。结论采用丙卡特罗联合西替利嗪对小儿咳嗽变异性哮喘进行治疗可有效控制病情发展,对炎性反应和过敏反应进行抑制,对于患儿临床症状的改善具有十分积极的意义,建议在临床进一步推广。
Objective Explore the use of joint procaterol cetirizine treatment of children with cough variant asthma clinical results. Methods Randomly selected in August 2014-July 2015 period cough variant asthma in 90 cases of children admitted to hospital, the use of random number table will be divided into a control group and observation group in which children in the control group using only procaterol treatment, observation group was combined with cetirizine treatment, clinical treatment of two groups of children were analyzed retrospectively. Results Observation group in which 91.11% percent of children treated effectively alleviate the symptoms of the control group was 75.56%, the overall effect of the treatment of children in the observation group than the control group, the difference was significant （P〈0.05）. Conclusion Procaterol joint use of cetirizine in children with cough variant asthma treatment can effectively control the progression of the disease, inflammatory and allergic reactions suppressed for improving the clinical symptoms of having a very positive sense, it is recommended further clinical.
出处
《中国医药指南》
2016年第21期19-19,21,共2页
Guide of China Medicine
